AISAP Cardio vs DeepTek CXR Analyzer
AI Verdict
Choose AISAP Cardio if…
Choose AISAP Cardio if your clinical setting requires rapid, comprehensive cardiac diagnostic assessments directly at the patient's bedside using point-of-care ultrasound. This tool is ideal for early detection of structural heart disease and heart failure, providing automated measurements like LVEF and valvular pathology assessments to inform immediate treatment decisions.
View AISAP Cardio →Choose DeepTek CXR Analyzer if…
Choose DeepTek CXR Analyzer if your radiology department aims to significantly improve the efficiency and accuracy of chest X-ray interpretation. This AI-powered CADe solution is best suited for automatically detecting and highlighting a wide range of suspicious regions across lung, pleural, and cardiac pathologies, thereby reducing radiologist workload and streamlining the diagnostic workflow.
View DeepTek CXR Analyzer →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AISAP Cardio | DeepTek CXR Analyzer |
|---|---|---|
| Pricing | Unknown | Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription. |
| Deployment | Cloud-based | On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AISAP CardioAISAP Cardio is designed for point-of-care ultrasound, enabling rapid, bedside diagnostics and empowering non-cardiologists with basic scanning skills to accurately interpret echocardiograms within minutes. This focus on expanding the user base beyond specialists and providing real-time guidance for image acquisition suggests a highly intuitive and accessible user experience.
Clinical Value
AISAP CardioBoth tools are FDA-cleared and offer substantial clinical value. However, AISAP Cardio's ability to enable non-cardiologists to perform expert-level cardiac diagnostics at the point of care, with validated 93% sensitivity and specificity for significant major valve diseases and high AUC for detecting reduced ejection fraction, offers a transformative clinical impact. This democratizes access to critical cardiac assessments, potentially leading to earlier detection and improved patient outcomes.
Pricing & Value
DeepTek CXR AnalyzerWhile neither tool publicly discloses specific pricing, DeepTek CXR Analyzer offers a 'pay-per-use' model and a 'complimentary pilot' program. This provides greater transparency and flexibility in cost structure, allowing potential customers to evaluate the solution with less initial commitment compared to AISAP Cardio's entirely opaque pricing.
Enterprise Readiness
DeepTek CXR AnalyzerDeepTek CXR Analyzer explicitly states HIPAA compliance and BAA availability in its structured facts, and offers both cloud and on-premise deployment options. This deployment flexibility and clear compliance posture provide a stronger foundation for enterprise adoption, catering to diverse IT infrastructure and security requirements.
Innovation
AISAP CardioAISAP Cardio's innovation lies in its pioneering FDA clearance for comprehensive POCUS diagnosis, enabling non-cardiologists to accurately interpret complex cardiac conditions at the bedside from limited views. This democratizes advanced cardiac diagnostics and represents a more disruptive innovation in healthcare delivery by bringing specialist-level capabilities to the point of care.
Support & Docs
TieNeither AISAP Cardio nor DeepTek CXR Analyzer provides readily available public information regarding their specific customer support offerings or comprehensive documentation. While DeepTek mentions '140+ Experts delivering 24x7 services' for its AI Assisted CXR Reporting Service, this does not explicitly detail product support and documentation for the software itself. Without more specific details for either, it is not possible to distinguish between them.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AISAP Cardio | DeepTek CXR Analyzer |
|---|---|---|
| Tool Name | AISAP Cardio | DeepTek CXR Analyzer |
| Primary Application | AI-powered point-of-care ultrasound (POCUS) software for rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. | AI-powered CADe solution for chest X-ray analysis, designed to assist radiologists by automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies. |
| Company | Aisap | DeepTek Medical Imaging Pvt |
| Key Modality | Point-of-care ultrasound (POCUS) | Chest X-ray |
| Target Pathologies/Measurements | Valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), Left Ventricle Ejection Fraction (LVEF), right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. | 28 findings covering lung, pleural, cardiac pathologies, and hardware. |
Videos
Demos, reviews, and walkthroughs featuring AISAP Cardio and DeepTek CXR Analyzer.